Myriad Genetics appointed Ben Wheeler as the new Chief Financial Officer, effective August 16, 2025.
Ben Wheeler has been with Myriad for over 13 years, starting as an assistant controller and progressing to key leadership positions.
Previous CFO Scott Leffler will transition to a consulting role until September 2, 2025, as Ben Wheeler takes over the CFO role.
Appointment of Ben Wheeler
Ben Wheeler, with extensive experience at Myriad Genetics, promoted to Chief Financial Officer.
Financial Guidance Affirmation
Company reaffirms its financial guidance for the full-year 2025, maintaining stability and commitment to investors.
Leadership Transition
Scott Leffler stepping down as CFO, transitioning to a consulting role as Ben Wheeler assumes CFO responsibilities.
- Ben Wheeler's promotion signifies Myriad Genetics' commitment to internal talent development and continuity in financial leadership.
- Reaffirmed financial guidance demonstrates stability and confidence in the company's growth strategy for the year.
Myriad Genetics secures a smooth transition in the CFO role with Ben Wheeler's appointment, reflecting the company's dedication to sustained growth and financial stability.